This inventor holds 2 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Myrexis, Inc., Panacos Pharmaceuticals, Inc.. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,697 
1 out of 12 
1 out of 4 Years Active: 2009-2012
Title: The Innovative Contributions of Karl Salzwedel in HIV Research
Introduction
Karl Salzwedel, an inventor based in Olney, Maryland, has made significant contributions to the field of HIV research, showcasing his innovative spirit through his patented inventions. With a total of two patents, Salzwedel's work primarily focuses on the inhibition of HIV-1 replication, addressing critical challenges in antiviral therapies.
Latest Patents
Salzwedel's latest patents include two innovations aimed at disrupting the processing of viral proteins related to HIV-1 replication. The first patent discusses the inhibition of HIV-1 replication by disrupting the processing of the viral Gag capsid (CA) protein from its precursor. It describes amino acid sequences that contain mutations in the Gag p25 protein, resulting in decreased inhibition of proteolytic processing. The patent also identifies compounds that can inhibit the HIV protease enzyme's interaction with Gag, offering a novel approach to combat HIV-1. The second patent reiterates these innovative methods, emphasizing the discovery of inhibitory compounds and their potential application in therapeutic outlines against HIV.
Career Highlights
Salzwedel has had a noteworthy career, with experience working for the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. He has also been associated with Myrexis, Inc., where he likely contributed to further advancements in biomedical research and health-related innovations.
Collaborations
Throughout his career, Karl Salzwedel has collaborated with prominent figures in the research community, including Feng Li and Carl Thomas Wild. These partnerships have likely enhanced the scope and impact of his work, fostering collaborative innovation in the field of HIV research.
Conclusion
Karl Salzwedel stands out as an influential inventor whose work in inhibiting HIV-1 replication represents significant advancements in medical research. His patents not only highlight his innovative thinking but also reflect a commitment to finding effective solutions for combating viral infections. As he continues his work, Salzwedel exemplifies the critical role inventors play in scientific progress and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile